Position in GILD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,538,568
-$120,213 QoQ
Shares Held
12,178
+2.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#917
of 2,266 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KEYNOTE FINANCIAL SERVICES LLC holds $25,265,456 across 9 Drug Manufacturers - General names. GILD ranks #8 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
38,262 | $9,628,249 | |
| 2 | JNJ |
Johnson & Johnson
|
11,963 | $3,038,243 | |
| 3 | LLY |
ELI LILLY & Co
|
2,030 | $2,434,843 | |
| 4 | PFE |
Pfizer Inc
|
94,489 | $2,275,295 | |
| 5 | AMGN |
Amgen Inc
|
6,280 | $2,274,113 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
33,564 | $1,933,957 | |
| 7 | MRK |
Merck & Co., Inc.
|
15,028 | $1,931,098 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
12,178 | $1,538,568 |
All Filings in GILD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,538,568 | 12,178 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,658,781 | 11,902 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,465,883 | 11,943 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,332,777 | 12,007 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,373,901 | 12,392 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,388,523 | 12,392 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,156,657 | 12,522 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,054,455 | 12,577 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $853,233 | 12,436 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $845,378 | 11,541 | Shares | Sole | 2024-06-13 | |
| No filing history on record for this holder in this stock. | ||||||